Tricida
0
0
+€0.00+0% 00:00 Today
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of TRC101, a non-absorbed orally-administered polymer that has completed phase 3 trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company was incorporated in 2013 and is headquartered in South San Francisco, California.
Show More
CEO
Dr. Gerrit Klaerner
Employees
64
Country
United States
ISIN
US89610F1012
WKN
000A2JPBU
Listings
0 Comments
Share your thoughts
FAQs
What is Tricida stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Tricida stocks are traded under the ticker 1T7.MU.
How many employees does Tricida have?▼
As of November 2, 2026, the company has 64 employees.
In which sector is Tricida located?▼
Tricida operates in the Health & Wellness sector.
When did Tricida complete a stock split?▼
Tricida has not had any recent stock splits.
Where is Tricida headquartered?▼
Tricida is headquartered in South San Francisco, United States.